Literature DB >> 17609277

Alpha interferon enhances TRIM5alpha-mediated antiviral activities in human and rhesus monkey cells.

Ryuta Sakuma1, Amber A Mael, Yasuhiro Ikeda.   

Abstract

Dominant, constitutively expressed antiretroviral factors, including TRIM5alpha and APOBEC3 proteins, are distinguished from the conventional innate immune systems and are classified as intrinsic immunity factors. Here, we demonstrate that interferon alpha (IFN-alpha) treatment upregulates TRIM5alpha mRNA in rhesus monkey cells, which correlates with the enhanced TRIM5alpha-mediated pre- and postintegration blocks of human immunodeficiency virus replication. In human cells, IFN-alpha increases the levels of TRIM5alpha mRNA, resulting in enhanced antiviral activity against N-tropic murine leukemia virus infection. These observations indicate that the TRIM5alpha-mediated antiviral effects can be orchestrated by the conventional innate immune response. It is conceivable that TRIM5alpha plays an essential role in controlling both the initial retroviral exposure and the subsequent viral dissemination in vivo.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17609277      PMCID: PMC2045407          DOI: 10.1128/JVI.00419-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

Review 1.  Lentiviral vectors and antiretroviral intrinsic immunity.

Authors:  Bastien Mangeat; Didier Trono
Journal:  Hum Gene Ther       Date:  2005-08       Impact factor: 5.695

Review 2.  Innate immune responses to infection.

Authors:  Michael F Tosi
Journal:  J Allergy Clin Immunol       Date:  2005-08       Impact factor: 10.793

3.  Murine retrovirus escapes from murine APOBEC3 via two distinct novel mechanisms.

Authors:  Aierken Abudu; Akifumi Takaori-Kondo; Taisuke Izumi; Kotaro Shirakawa; Masayuki Kobayashi; Amane Sasada; Keiko Fukunaga; Takashi Uchiyama
Journal:  Curr Biol       Date:  2006-08-08       Impact factor: 10.834

4.  A retrovirus restriction factor TRIM5alpha is transcriptionally regulated by interferons.

Authors:  Kentaro Asaoka; Kazuhiro Ikeda; Toshiki Hishinuma; Kuniko Horie-Inoue; Satoru Takeda; Satoshi Inoue
Journal:  Biochem Biophys Res Commun       Date:  2005-11-11       Impact factor: 3.575

5.  Interferon downregulates CXCR4 (fusin) gene expression in peripheral blood mononuclear cells.

Authors:  Y Shirazi; P M Pitha
Journal:  J Hum Virol       Date:  1998 Jan-Feb

6.  Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells.

Authors:  Ya-Lin Chiu; Vanessa B Soros; Jason F Kreisberg; Kim Stopak; Wes Yonemoto; Warner C Greene
Journal:  Nature       Date:  2005-04-13       Impact factor: 49.962

7.  Cyclosporine increases human immunodeficiency virus type 1 vector transduction of primary mouse cells.

Authors:  Josh A Noser; Greg J Towers; Ryuta Sakuma; Jean-Maurice Dumont; Mary K L Collins; Yasuhiro Ikeda
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

8.  Alpha interferon potently enhances the anti-human immunodeficiency virus type 1 activity of APOBEC3G in resting primary CD4 T cells.

Authors:  Keyang Chen; Jialing Huang; Chune Zhang; Sophia Huang; Giuseppe Nunnari; Feng-xiang Wang; Xiangrong Tong; Ling Gao; Kristi Nikisher; Hui Zhang
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

9.  The human and African green monkey TRIM5alpha genes encode Ref1 and Lv1 retroviral restriction factor activities.

Authors:  Zuzana Keckesova; Laura M J Ylinen; Greg J Towers
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

Review 10.  TRIM family proteins: retroviral restriction and antiviral defence.

Authors:  Sébastien Nisole; Jonathan P Stoye; Ali Saïb
Journal:  Nat Rev Microbiol       Date:  2005-10       Impact factor: 60.633

View more
  53 in total

1.  Modulation of TRIM5alpha activity in human cells by alternatively spliced TRIM5 isoforms.

Authors:  Emilie Battivelli; Julie Migraine; Denise Lecossier; Saori Matsuoka; Danielle Perez-Bercoff; Sentob Saragosti; François Clavel; Allan J Hance
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

Review 2.  Novel approaches to inhibiting HIV-1 replication.

Authors:  Catherine S Adamson; Eric O Freed
Journal:  Antiviral Res       Date:  2009-09-24       Impact factor: 5.970

Review 3.  Retroviral restriction and dependency factors in primates and carnivores.

Authors:  Hind J Fadel; Eric M Poeschla
Journal:  Vet Immunol Immunopathol       Date:  2011-06-12       Impact factor: 2.046

4.  Viral attachment induces rapid recruitment of an innate immune sensor (TRIM5α) to the plasma membrane.

Authors:  Seiga Ohmine; Raman Deep Singh; David L Marks; Melissa A Meyer; Richard E Pagano; Yasuhiro Ikeda
Journal:  J Innate Immun       Date:  2013-03-21       Impact factor: 7.349

5.  Determinants for the rhesus monkey TRIM5alpha-mediated block of the late phase of HIV-1 replication.

Authors:  Ryuta Sakuma; Seiga Ohmine; Yasuhiro Ikeda
Journal:  J Biol Chem       Date:  2009-12-01       Impact factor: 5.157

6.  Porcine endogenous retroviruses PERV A and A/C recombinant are insensitive to a range of divergent mammalian TRIM5alpha proteins including human TRIM5alpha.

Authors:  Andrew Wood; Benjamin L J Webb; Birke Bartosch; Torsten Schaller; Yasuhiro Takeuchi; Greg J Towers
Journal:  J Gen Virol       Date:  2009-03       Impact factor: 3.891

Review 7.  Innate immunity against HIV: a priority target for HIV prevention research.

Authors:  Persephone Borrow; Robin J Shattock; Annapurna Vyakarnam
Journal:  Retrovirology       Date:  2010-10-11       Impact factor: 4.602

8.  TRIM5 suppresses cross-species transmission of a primate immunodeficiency virus and selects for emergence of resistant variants in the new species.

Authors:  Andrea Kirmaier; Fan Wu; Ruchi M Newman; Laura R Hall; Jennifer S Morgan; Shelby O'Connor; Preston A Marx; Mareike Meythaler; Simoy Goldstein; Alicia Buckler-White; Amitinder Kaur; Vanessa M Hirsch; Welkin E Johnson
Journal:  PLoS Biol       Date:  2010-08-24       Impact factor: 8.029

9.  Human TRIM gene expression in response to interferons.

Authors:  Laetitia Carthagena; Anna Bergamaschi; Joseph M Luna; Annie David; Pradeep D Uchil; Florence Margottin-Goguet; Walther Mothes; Uriel Hazan; Catherine Transy; Gianfranco Pancino; Sébastien Nisole
Journal:  PLoS One       Date:  2009-03-17       Impact factor: 3.240

10.  Restriction of HIV-1 replication in monocytes is abolished by Vpx of SIVsmmPBj.

Authors:  Silke Schüle; Björn-Philipp Kloke; Julia K Kaiser; Sabine Heidmeier; Sylvia Panitz; Nina Wolfrum; Klaus Cichutek; Matthias Schweizer
Journal:  PLoS One       Date:  2009-09-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.